Vascular Disease

Stephen Kopecky, MD, on CV Biomarkers, Anticoagulation Management in AFib, and More

09/25/2018

 

 

Dr Stephen Kopecky from Mayo Clinic talks about his 3 sessions at the ASPC's 2018 Congress: cardiovascular disease biomarkers, lipid testing, managing atrial fibrillation with anticoagulation therapy, and the effect of testosterone therapy on cardiovascular events.

 

Stephen L. Kopecky, MD, is a professor of medicine and consultant in cardiovascular diseases and internal medicine at Mayo Clinic in Rochester, Minnesota.

 

 

References:

 

Yeboah J, Young R, McClelland RL, et al. Utility of nontraditional risk markers in atherosclerotic cardiovascular disease risk assessment. J Am Coll Cardiol. 2016;67(2):139-147. doi:10.1016/j.jacc.2015.10.058.

 

Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation. 2009;119(7):931-939. https://doi.org/10.1161/CIRCULATIONAHA.108.816181. 

 

Kavousi M, Elias-Smale S, Rutten JH, et al. Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study. Ann Intern Med. 2012;156(6):438-444. doi:10.7326/0003-4819-156-6-201203200-00006.

 

January CT, Wann LS, Alpert JS, et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-76. doi:10.1016/j.jacc.2014.03.022.

 

Kloner RA, Carson C, Dobs A, Kopecky S, Mohler ER. Testosterone and cardiovascular disease. J Am Coll Cardiol. 2016;67(5):545-557. doi:10.1016/j.jacc.2015.12.005.

 

Gupta BP, Murad MH, Clifton MM, Prokop L, Nehra A, Kopecky SL. The effect of lifestyle modification and cardiovascular risk factor reduction on erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2011;171(20):1797-1803. doi:10.1001/archinternmed.2011.440.

 

 

 

Related Content

Osteoporosis
Osteoporosis
Sonali Thosani, MD, on Bone Health Among Long-Term Cancer Survivors
09/12/2019
Dr Thosani, from The University of Texas MD Anderson Cancer Center, discusses the management of bone health among long-term cancer survivors, the importance of osteoporosis screening, and more.
09/12/2019
Vaccines
Vaccines
Cherise Rohr-Allegrini, PhD, MPH, on Vaccine-Preventable Outbreaks
05/24/2019
Cherise Rohr-Allegrini, PhD, MPH, discusses a timeline of vaccinations, what opting out of these vaccines means for the future of outbreaks, and what the public should learn from these outbreaks.
05/24/2019
Inflammatory Bowel Disease
Inflammatory Bowel Disease
David T. Rubin, MD, on 'We've Moved the Needle Quite Far' in Management of Crohn Disease
10/29/2018
Dr David T Rubin from the University of Chicago Medicine discusses how the management of Crohn disease has changed over time, the importance of understanding the disease for...
10/29/2018
AHA Scientific Sessions
AHA Scientific Sessions
Erin Michos, MD, on Reducing CVD Outcomes With Influenza Vaccination
02/05/2022
In this podcast, Dr Michos, from Johns Hopkins University School of Medicine, talks about her latest study on how the influenza vaccine effects mortality and morbidity outcomes among patients with...
02/05/2022
Epilepsy
Epilepsy
Barbara Dworetzky, MD, on the Challenges of Diagnosing PNES
12/30/2019
She outlines the challenges associated with diagnosing psychogenic nonepileptic seizures (PNES), how neurologists and other providers can overcome these challenges, and more.
12/30/2019